[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Specialsituationz posts on X about $vtyx, $260m, $200m, $400m the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance
Social topic influence $vtyx #2, $260m, $200m, $400m, po, discount, $pali, sec, $mltx, $skye
Top assets mentioned MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
Top posts by engagements in the last XX hours
"$VTYX worth a look. MC ($260m) barely above cash ($200m) with a readout q4 in pericarditis where market has mispriced chance of success. One competitor with $400m in sales. Biomarker data suggest activity at target with benefit of PO over SC. Tang own 5%"
X Link @hannibalspeaks 2025-10-04T17:14Z XXX followers, 2445 engagements
"@houndcl What's Apogee or Kymera then Crazy but a market darling can hit billion dollor valuation. Riding that wave not a bad idea"
X Link @hannibalspeaks 2025-10-08T20:39Z XXX followers, 1284 engagements
"Investing is partially about truth it's also about perception. If a small cap produces a signal in obesity it could 10x on perception alone. Same company pre-GLP1 would trade at a discount. Market perception matters"
X Link @hannibalspeaks 2025-10-08T20:56Z XXX followers, XXX engagements
"Apogee will be the next $MLTX"
X Link @hannibalspeaks 2025-10-08T19:58Z XXX followers, 3353 engagements
"@Sanctuary_Bio Doesnt look like they will accept defeat either. Some nonsense about suboptimal dosing. Despite 200mg weekly The X% delta with GLP1 looks spinable"
X Link @hannibalspeaks 2025-10-06T13:35Z XXX followers, XXX engagements
"This is because market is assigning some value to synergy with GLP1 (3%). Obesity is so hyped that a fluke hit for $VTYX will be insanely consequential"
X Link @hannibalspeaks 2025-10-06T17:15Z XXX followers, XXX engagements